Chairman of the Board
Michael Heffernan is the Chairman of the Board of Directors at Avalo Therapeutics, appointed in March 2025, succeeding Dr. Garry Neil in that role while Neil remains CEO. He is a seasoned biopharmaceutical executive with over 30 years of experience, including founding and leading Collegium Pharmaceu